Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Editor information Editors and Affiliations Rights and permissions Copyright information 2022 Springer Nature Switzerland AG About this chapter Cite this chapter Peters, V., Zschocke, J
Group A who were given tranexamic acid showed a slight edge over glutathione in the response to therapy
Future multi-receptor therapeutics may need individualized strategies tailored to individual receptor expression profiles or metabolic characteristics
Zierold et al
The meta-analyses in this age group show clear benefits for lean mass preservation and functional strength
Typically, GLP-1 treatment is started with a low dosage and then gradually rise to the higher doses, if tolerable
US$ 20.68
US$ 26.86
US$ 22.23
US$ 29.61
US$ 21.64
US$ 25.96
US$ 26.49
US$ 25.42
US$ 22.07
